Skip to content
Open access

Antiretroviral Therapy Adherence and Treatment Duration as Predictors of Viral Load Suppression among Children and Adolescents in Nasarawa State, Nigeria

Aug 2026 · Journal of Clinical Practice and Medical Research · Vol 2, pp. 67-74 · 0 citations · 9 references

TL;DR

HIV suppression did not differ between current people living with HIV and 'recent' initiators of ART (those with at least six months' HIV treatment), and adjustment for household income revealed that after it, ART duration ≥ six months was an independent predictor of high odds of suppression, while poor adherence was an independent predictor of low odds of suppression.

Abstract

Children and adolescents on antiretroviral therapy (ART) are safe, but viral-load non-suppression is still a huge risk to health and survival. The general objective of this study was to estimate the rate of viral load non-suppression and to determine factors associated with it among children and adolescents (0-19 years) on ART in 6 LGAs in Nasarawa State, Nigeria. The study design was an analytical cross- sectional study with structured interviews with participants/caregivers and abstraction of clinical records. Data from 564 participants were obtained and analysed using descriptive statistics, the chi-square test, crude and risk ratios, with the absolute prevalence difference at P< 0.05, and a multivariable logistic regression was also performed. Overall, 497 participants (88.1%; 95% CI: 85.2–90.5) were virally suppressed, whereas 67 (11.9%; 95% CI: 9.5–14.8) were unsuppressed. Participants with good adherence had significantly higher suppression than those with poor adherence (93.7% versus 69.4%), a 24.3-percentage-point difference. Other than the differences above, HIV suppression did not differ between current people living with HIV and 'recent' initiators of ART (those with at least six months' HIV treatment). Adjustment for household income revealed that after it, ART duration ≥ six months (aOR = 6.68; 95% CI: 1.69–26.70), was an independent predictor of high odds of suppression, while poor adherence was an independent predictor of low odds of suppression (aOR = 0.15; 95% CI: 0.05–0.43). Hence, there is a need for increased compliance counselling and early follow-up, together with the sustainable delivery of uninterrupted treatment.

Read PDF

Similar papers

Review Aug 2026

Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort Study.

Viral suppression and ART adherence were high among AYLHIV in AFRICOS and clinic site and ART regimen were associated with outcomes, highlighting the importance of health system factors.

M. Brault, Aima A. Ahonkhai, Seth Frndak et al. · 0 citations
Open access Sep 2026

Adherence to antiretroviral therapy and drug resistance impact evolving viral suppression among a cohort of children and adolescents living with perinatal HIV infection in western Kenya

Non-adherence among Kenyan CALWH was common and resulted in increased risks for TF and extensive DR, highlighting treatment challenges and well characterized non-adherence among Kenyan CALWH.

Rachel Vreeman, Winstone Nyandiko, Allison Delong et al. · 0 citations
Open access Aug 2026

Factors Associated With Viral Suppression Among People Living With HIV (PLWH) in Kermanshah, Iran: A Retrospective Cohort Study

ABSTRACT Background and Aims Despite the expanded availability of antiretroviral therapy (ART), HIV remains a major global health challenge. Viral load (VL) is the main indicator used to assess treatment response, and viral suppression is the ultimate goal of therapy. However, virological response is influenced by vari...

E. Javadirad, M. Rostamian, Seyedeh Shadi Vaziri et al. · 0 citations
Sep 2026

Genotype-guided antiretroviral therapy outcomes in routine clinical practice: a retrospective study of HIV viral load suppression at 6 and 12 months in Uganda.

This study assessed virological outcomes following genotype-guided antiretroviral therapy (GART). We conducted a retrospective cohort of 235 PLHIV (2021-2023) post-GART after virological failure, analyzing baseline characteristics, 6- and 12-month viral load outcomes, and suppression factors using descriptive statistic...

Collins Ankunda, Jude Emunyu, S. Namasambi et al. · 0 citations
Open access Sep 2026

A comparison of adherence to antiretroviral medications in Human Immunodeficiency Virus depressed and non-depressed patients

A high level of adherence to Antiretroviral Treatment (ART) of at least 95% is needed for optimal suppression of Human Immunodeficiency Virus (HIV)’s RNA. Non-adherence's consequences have severe implications for managing People Living with HIV (PLHIV). Adherence predicts virologic outcomes in a dose-dependent manner....

M. M. Umar, Z. G. Habib, Musa U. Umar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.